Organic Coagulants
Coagulants destabilize the colloidal system by neutralizing forces of various nature that ensure its stability.
Coagulation was previously performed using inorganic coagulants, such as aluminum sulfate and ferric chloride (before the advent of synthetic organic polymers in the 1960s). At first, polymer coagulants were used as an additive to inorganic coagulants for more intensive flake formation. Today, polymer coagulants are used as basic coagulants, completely or partially replacing inorganic coagulants.
Coagulants of the polymer type proved to be more economical in a wide range of processes, including sedimentation, flotation and filtration. For these processes, polymer coagulants have proven their ability to stably ensure the quality of purified water that meets the established standards, with optimum reliability, efficiency and economy.
Organic Coagulants FLOQUAT™ series
A series of polymeric coagulants FLOQUAT™ provides:
Advanteges
Coagulants of polymeric type in comparison with inorganic coagulants have the following advantages:
SNF Floerger is a leading manufacturer of two main types of organic cationic coagulants:
FLOQUAT™ FL series
Our quaternary polyamines are produced by condensation reaction of primary or secondary amines on epichlorohydrin. By controlling the sequence of monomer addition to the reactor, we can vary the molecular weight in the range of 10,000 to 1,000,000.
The specific cationic charge and binding capacity of these coagulants is determined precisely by the action of amines. Polyamines differ from other polyelectrolytes in that their cationic charge is located on the main molecular chain.
Basic properties:
Technical data:
Water soluble cationic polymers in liquid form The FLOQUAT ™ series
Polymer | FL 28 P1 | FL 28 P2 | FL 28 P3 | FL 17 | FL 28 P4 | FL 18-40 |
---|---|---|---|---|---|---|
Сharge continuity | Very high | Very high | Very high | Very high | Very high | Very high |
Density | 1,12 – 1,16 | 1,10 – 1,16 | 1,14 – 1,18 | 1,12 – 1,16 | 1,10 – 1,16 | 1,12 – 1,16 |
Approx. Brookfield viscosity (cPs) | 100 – 200 | 200 – 400 | 300 – 500 | 600 – 1000 | 1000 – 4000 | 1300 – 2200 |
pH | 5,5 – 8,0 | 4,0 – 7,0 | 2,5 – 3,5 | 4,0 – 7,0 | 4,0 – 5,0 | 4,0 – 7,0 |
Active substance concentration (%) | 48 – 51 | 48 – 51 | 48 – 51 | 48 – 51 | 48 – 51 | 38 – 41 |
Stability (months) | 24 | 24 | 24 | 24 | 24 | 24 |
Storage temperature (°C) | 0 – 50 | 0 – 50 | 0 – 50 | 0 – 50 | 0 – 50 | 0 – 50 |
Freezing point (°C)) | -3 | -3 | -3 | -3 | -3 | -3 |
Packing:
plastic braided bottle 25 kg / plastic barrel 225 kg / container 1100 kg / other containers on request.
All these data are provided for information only. They can not be regarded as a specification and do not guarantee the use or any dependence on existing patents.
PolyDADMAC
FLOQUAT™ FL 45 series
PolyDADMAC coagulants (diallyldimethylammonium chloride) are synthesized from allyl chloride and dimethylamine. The reactivity of the allyl radical in DADMAC during polymerization limits the molecular weight of the polymer.
Basic properties:
Technical data:
Soluble in water cationic polymers in liquid form.
Polymer | FL 45 DL | FL 45 | FL 45 VHM | FL 45 CLV | FL 45 C |
---|---|---|---|---|---|
Сharge continuity | Very high | Very high | Very high | Very high | Very high |
Density | 1,02 – 1,06 | 1,02 – 1,06 | 1,02 – 1,06 | 1,08 – 1,09 | 1,08 – 1,09 |
Approx. Brookfield viscosity (cPs) | 50 – 100 | 200 – 400 | 600 – 900 | 1000 – 3000 | 8000 – 13000 |
pH | 4,0 – 7,0 | 4,0 – 7,0 | 5,0 – 7,0 | 4,0 – 7,0 | 5,0 – 7,0 |
Active substance concentration (%) | 19 – 21 | 19 – 21 | 19 – 21 | 39 – 41 | 39 – 41 |
Stability (months) | 24 | 24 | 24 | 24 | 24 |
Storage temperature (°C) | 0 – 50 | 0 – 50 | 0 – 50 | 0 – 50 | 0 – 50 |
Freezing point (°C)) | -3 | -3 | -3 | -3 | -3 |
Packing:
plastic braided bottle 25 kg / plastic barrel 210 kg / container 1100 kg (FL 45 VHM, CLV, C) / container 1050 kg (FL 45 DL, FL 45) / other containers on request.
All these data are provided for information only. They can not be regarded as a specification and do not guarantee the use or any dependence on existing patents.